Cargando…

Intact plasma quantification of the large therapeutic lipopeptide bulevirtide

Bulevirtide is a first-in-class entry inhibitor of the hepatitis B and hepatitis delta virus blocking the sodium/bile acid co-transporter NTCP, and was recently approved for the treatment of hepatitis D as a priority medicine (prime) in an accelerated assessment by the European Medicines Agency. It...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sauter, Max, Blank, Antje, Stoll, Felicitas, Lutz, Natalie, Haefeli, Walter E., Burhenne, Jürgen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410713/ https://www.ncbi.nlm.nih.gov/pubmed/34018034 http://dx.doi.org/10.1007/s00216-021-03384-7

Ejemplares similares

Metabolic Effect of Blocking Sodium-Taurocholate Co-Transporting Polypeptide in Hypercholesterolemic Humans with a Twelve-Week Course of Bulevirtide—An Exploratory Phase I Clinical Trial
por: Stoll, Felicitas, et al.
Publicado: (2022)

Evaluation of the drug-drug interaction potential of the novel hepatitis B and D virus entry inhibitor bulevirtide at OATP1B in healthy volunteers
por: Zhu, Vanessa, et al.
Publicado: (2023)

Development and Validation of an LC–MS-Based Quantification Assay for New Therapeutic Antibodies: Application to a Novel Therapy against Herpes Simplex Virus
por: Fresnais, Margaux, et al.
Publicado: (2020)

Ultra-sensitive bioanalysis of the therapeutic peptide exenatide for accurate pharmacokinetic analyses at effective plasma concentrations utilizing UPLC-MS/MS
por: Sauter, Max, et al.
Publicado: (2020)

Frailty as a Marker for the Plasma Concentrations of Direct Oral Anticoagulants in Older Patients: Results of an Exploratory Study
por: Eidam, Annette, et al.
Publicado: (2023)

CYP3A and CYP2C19 Activity Determined by Microdosed Probe Drugs Accurately Predict Voriconazole Clearance in Healthy Adults
por: Muhareb, Amin, et al.
Publicado: (2023)

Rapid and Sensitive Quantification of Intracellular Glycyl-Sarcosine for Semi-High-Throughput Screening for Inhibitors of PEPT-1
por: von Linde, Teresa, et al.
Publicado: (2021)

Simultaneous Quantification and Pharmacokinetic Characterization of Doxapram and 2-Ketodoxapram in Porcine Plasma and Brain Tissue
por: Kraft, Manuel, et al.
Publicado: (2022)

An Underestimated Factor: The Extent of Cross-Reactions Modifying APIs in Surface-Modified Liposomal Preparations Caused by Comprised Activated Lipids
por: Sauter, Max, et al.
Publicado: (2020)

Functional Characterization of the Solute Carrier LAT-1 (SLC7A5/SLC2A3) in Human Brain Capillary Endothelial Cells with Rapid UPLC-MS/MS Quantification of Intracellular Isotopically Labelled L-Leucine
por: Bay, Cindy, et al.
Publicado: (2022)

Correction: Bay et al. Functional Characterization of the Solute Carrier LAT-1 (SLC7A5/SLC3A2) in Human Brain Capillary Endothelial Cells with Rapid UPLC-MS/MS Quantification of Intracellular Isotopically Labelled L-Leucine. Int. J. Mol. Sci. 2022, 23, 3637
por: Bay, Cindy, et al.
Publicado: (2023)

Pharmacoenhancement of Low Crizotinib Plasma Concentrations in Patients with Anaplastic Lymphoma Kinase‐Positive Non‐Small Cell Lung Cancer using the CYP3A Inhibitor Cobicistat
por: Hohmann, Nicolas, et al.
Publicado: (2020)

Impact of pantoprazole on absorption and disposition of hydroxychloroquine, a drug used in Corona Virus Disease-19 (Covid-19): A structured summary of a study protocol for a randomised controlled trial
por: Stoll, Felicitas, et al.
Publicado: (2020)

Evaluation of PepT1 (SLC15A1) Substrate Characteristics of Therapeutic Cyclic Peptides
por: Bajraktari-Sylejmani, Gzona, et al.
Publicado: (2022)

Bulevirtide in the Treatment of Hepatitis Delta: Drug Discovery, Clinical Development and Place in Therapy
por: Soriano, Vicente, et al.
Publicado: (2023)

Rapid and Sensitive Quantification of Osimertinib in Human Plasma Using a Fully Validated MALDI–IM–MS/MS Assay
por: Fresnais, Margaux, et al.
Publicado: (2020)

Evaluation of CYP2C19 activity using microdosed oral omeprazole in humans
por: Elbe, Annika, et al.
Publicado: (2022)

Perpetrator Characteristics of Azole Antifungal Drugs on Three Oral Factor Xa Inhibitors Administered as a Microdosed Cocktail
por: Rohr, Brit Silja, et al.
Publicado: (2021)

Investigating the Central Nervous System Disposition of Actinomycin D: Implementation and Evaluation of Cerebral Microdialysis and Brain Tissue Measurements Supported by UPLC-MS/MS Quantification
por: Benzel, Julia, et al.
Publicado: (2021)

Treatment of Chronic Hepatitis D with Bulevirtide—A Fight against Two Foes—An Update
por: Ferenci, Peter, et al.
Publicado: (2022)

Bulevirtide als erster spezifischer Wirkstoff gegen Hepatitis-D-Virusinfektionen – Mechanismus und klinische Wirkung
por: Nkongolo, Shirin, et al.
Publicado: (2022)

Desorption Kinetics Evaluation for the Development of Validated Desorption Electrospray Ionization-Mass Spectrometric Assays for Drug Quantification in Tissue Sections
por: Fresnais, Margaux, et al.
Publicado: (2023)

Long-term follow-up of patients discontinuing bulevirtide treatment upon long-term HDV-RNA suppression
por: Jachs, Mathias, et al.
Publicado: (2023)

Broad-spectrum activity of bulevirtide against clinical isolates of HDV and recombinant pan-genotypic combinations of HBV/HDV
por: Mateo, Roberto, et al.
Publicado: (2023)

Response‐guided long‐term treatment of chronic hepatitis D patients with bulevirtide—results of a “real world” study
por: Jachs, Mathias, et al.
Publicado: (2022)

Quantification of Biologically Active DNA Alkylation in Temozolomide-Exposed Glioblastoma Cell Lines by Ultra-Performance Liquid Chromatography–Tandem Mass Spectrometry: Method Development and Recommendations for Validation
por: Fresnais, Margaux, et al.
Publicado: (2023)

Efficacy and Safety of Bulevirtide plus Tenofovir Disoproxil Fumarate in Real-World Patients with Chronic Hepatitis B and D Co-Infection
por: Herta, Toni, et al.
Publicado: (2022)

Drug Treatment of Hypercholesterolemia in Older Adults: Focus on Newer Agents
por: Stoll, Felicitas, et al.
Publicado: (2022)

Rapid MALDI-MS Assays for Drug Quantification in Biological Matrices: Lessons Learned, New Developments, and Future Perspectives
por: Fresnais, Margaux, et al.
Publicado: (2021)

Quantification of the Time Course of CYP3A Inhibition, Activation, and Induction Using a Population Pharmacokinetic Model of Microdosed Midazolam Continuous Infusion
por: Nassar, Yomna M., et al.
Publicado: (2022)

Important Requirements for the Selection of Internal Standards during the Development of Desorption/Ionization Assays for Drug Quantification in Biological Matrices—A Practical Example
por: Fresnais, Margaux, et al.
Publicado: (2022)

Lipopeptides for Vaccine Development
por: Hamley, Ian W.
Publicado: (2021)

Opportunistic Challenges of Computer-aided Drug Discovery of Lipopeptides: New Insights for Large Molecule Therapeutics
por: Yadav, Manisha, et al.
Publicado: (2023)

Substantially increased sildenafil bioavailability after sublingual administration in children with congenital heart disease: two case reports
por: Carls, Alexandra, et al.
Publicado: (2014)

Oral bioavailability of microdoses and therapeutic doses of midazolam as a 2-dimensionally printed orodispersible film in healthy volunteers
por: Breithaupt, Mareile H., et al.
Publicado: (2022)

Application of a microdosed cocktail of 3 oral factor Xa inhibitors to study drug–drug interactions with different perpetrator drugs
por: Mikus, Gerd, et al.
Publicado: (2020)

Analytical Performance Evaluation of New DESI Enhancements for Targeted Drug Quantification in Tissue Sections
por: Fresnais, Margaux, et al.
Publicado: (2022)

Lipopeptides as the Antifungal and Antibacterial Agents: Applications in Food Safety and Therapeutics
por: Meena, Khem Raj, et al.
Publicado: (2015)

Peptide hormones and lipopeptides: from self‐assembly to therapeutic applications
por: Hutchinson, J. A., et al.
Publicado: (2017)

First‐in‐human, randomized, double‐blind, placebo‐controlled, dose escalation trial of the anti‐herpes simplex virus monoclonal antibody HDIT101 in healthy volunteers
por: Blank, Antje, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jhncfll0td148sj8v9d4uofcub